Coeliac disease in children with type 1 diabetes

Kalle Kurppa1, Anna Laitinen1, Daniel Agardh2

  • 1Centre for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland.

Insights

Type 1 diabetes and coeliac disease are common paediatric autoimmune disorders that often coexist. This review covers diagnosis, treatment, and shared mechanisms for children with both conditions, emphasizing screening and dietary challenges.

Area of Science:

  • Pediatric autoimmune disorders
  • Immunology
  • Gastroenterology

Background:

  • Type 1 diabetes and coeliac disease are the most frequent autoimmune conditions in children.
  • Both disorders show increasing incidence and frequently occur together in the same patient.
  • Shared genetic and immunological factors underlie these coexisting conditions.

Purpose of the Study:

  • To review diagnostic and treatment strategies for children with coeliac disease and type 1 diabetes.
  • To emphasize the challenges associated with a double diagnosis.
  • To explore screening efficacy, dietary management, and shared pathogenic mechanisms.

Main Methods:

  • Literature review of diagnostic and treatment approaches.
  • Analysis of screening protocols for coeliac disease in type 1 diabetes patients.
  • Examination of genetic and immunological data.
  • Discussion of dietary management challenges.

Main Results:

  • Coeliac disease diagnosis in children with type 1 diabetes often relies on screening due to subtle symptoms.
  • Screening for coeliac disease in this population has specific pros and cons.
  • Dietary management presents unique challenges for children with both type 1 diabetes and coeliac disease.
  • Recent research highlights shared genetic and pathogenic pathways.

Conclusions:

  • Early diagnosis and tailored management are crucial for children with coeliac disease and type 1 diabetes.
  • Screening protocols require careful consideration of benefits and drawbacks.
  • Addressing the complexities of dietary adherence is essential for improving patient outcomes.
  • Further research into shared mechanisms may reveal novel therapeutic targets.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
505
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
306